Early intravenous thrombolysis for acute ischemic stroke in a community- based approach

Stroke

Volumn 29, Issue 8, 1998, Pages 1544-1549

  Grond, Martin ^b   Stenzel, Christoph ^b   Schmülling, Susanne ^b   Rudolf, Jobst ^b   Neveling, Michael ^b   Lechleuthner, Alex ^b   Schneweis, Susanne ^b   Heiss, Wolf Dieter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

Stroke acute thrombolytic; Stroke management; Therapy

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031928555     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.8.1544     Document Type: Article

References (31)

1. The National Institute of Neurological Disorders and Stroke r-tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274: 1017-1025.
3. del Zoppo GJ. Acute stroke: on the threshold of a therapy? N Engl J Med. 1995;333:1632-1633.
4. Grotta J. t-PA: the best current option for most patients. N Engl J Med. 1997;337:1310-1312.
5. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason C, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-1174.
6. Lyden P, Grotta J, Levine SR, Marler JR, Frankel MR, Brott TG. Intravenous thrombolysis for acute stroke. Neurology. 1997;49:14-20.
7. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, and the NINDS TPA Stroke Study Group. Improved reliability of the NIH stroke scale using video training. Stroke. 1994;25: 2220-2226.
8. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J. 1965;14:61-65.
9. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
10. Hacke W, Toni D, Steiner T, Kaste M, von Kummer R, Fieschi C, Bluhmki E, for the ECASS Study Group. rt-PA in acute ischemic stroke-results from the ECASS three hour cohort. Stroke. 1997;28:272. Abstract.
11. Pessin MS, Del Zoppo GJ, Estol CJ. Thrombolytic agents in the treatment of strokes. Clin Neuropharmacol. 1990;13:271-289.
12. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382-390.
13. von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
14. Trouillas P, Nighoghossian N, Getenet JC, Riche G, Neuschwander P, Froment JC, Turjman F, Jin JX, Malicier D, Fournier G, Gabry AL, Ledoux X, Derex L, Berthezène Y, Adeleine P, Xie J, Ffrench P, Dechavanne M. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Stroke. 1996;27:882-890.
15. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42:976-982.
16. Yamaguchi T, Hayakawa T, Kiuchi H, for the Japanese Thrombolysis Study Group. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis. 1993;3:269-272.
17. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marler JR. Urgent therapy for stroke, part I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
18. Haley EC, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Tomer JC, Marler JR. Urgent therapy for stroke, part II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
19. Haley EC Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marler JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC, for the TPA Bridging Study Group. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke. 1993;24:1000-1004.
20. Del Zoppo GJ, Poeck K, Pessin MS, Wopert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
21. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety and efficacy in the first year of clinical practice. Stroke. 1998;29:18-22.
22. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 1992;23:352-356.
23. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marler JR. Urgent therapy for acute stroke: effects of a stroke trial on untreated patients. Stroke. 1994;25:2132-2137.
24. The NINDS rt-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-2125.
25. Von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hacke W. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997;205: 327-333.
26. Grond M, von Kummer R, Sobesky J, Schmülling S, Heiss WD. Early computed-tomography abnormalities in acute stroke. Lancet. 1997;350: 1595-1596.
27. Heiss WD, Grond M, Thiel A, Stockhausen HM, Rudolf J. Ischemic brain tissue salvaged from infarction with alteplase. Lancet. 1997;349: 1599-1600.
28. Tanne D, Mansbach HH, Verro P, Binder JR, Karanjia PN, Dayno J, Dulli D, Book D, Levine SR, and the rt-PA in Clinical Practice Stroke Survey Group. Intravenous rt-PA therapy for stroke in clinical practice: a multicenter evaluation of outcome. Stroke. 1998;29:288. Abstract.
29. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28: 2109-2118.
30. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischemic stroke. Lancet. 1997; 349:1569-1581.
31. Gunnar RM, Passamani ER, Bourdillon PDV, Dixon DW, Fuster V, Karp RB, Kennedy JW, Klocke FJ, Pitt B, Rapaport E, Reeves TJ, Russel RO Jr, Sobel BE, Winter WL Jr. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol. 1990;16:249-292.